Up-front mutation detection in circulating tumor DNA by droplet digital PCR has added diagnostic value in lung cancer

Therapy Monitoring of EGFR Positive Non-Small Cell Lung Cancer Patients using ddPCR Multiplex Assays Monitoring NSCLC patients by ddPCR

(2021) Remco de Kock et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021

(2021) David S. Ettinger et al.   Journal of the National Comprehensive Cancer Network

Lung Cancer in the Netherlands

(2021) Lizza E.L. Hendriks et al.   Journal of Thoracic Oncology

Targeted Therapy in Advanced and Metastatic Non-Small Cell Lung Cancer. An Update on Treatment of the Most Important Actionable Oncogenic Driver Alterations

(2021) David König et al.   Cancers

Diagnostic Accuracy of Droplet Digital PCR and Amplification Refractory Mutation System PCR for Detecting EGFR Mutation in Cell-Free DNA of Lung Cancer: A Meta-Analysis

(2020) Caichen Li et al.   Frontiers in Oncology

Differences in the genomic profiles of cell‐free DNA between plasma, sputum, urine, and tumor tissue in advanced NSCLC

(2019) Zhen Wu et al.   Cancer Medicine

Optimized (Pre) Analytical Conditions and Workflow for Droplet Digital PCR Analysis of Cell-Free DNA from Patients with Suspected Lung Carcinoma

(2019) Remco de Kock et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Detection of rare and novel EGFR mutations in NSCLC patients: Implications for treatment-decision

(2019) AC. Sousa et al.   LUNG CANCER

Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology

(2018) Neal I. Lindeman et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

OUP accepted manuscript

(2018)   ANNALS OF ONCOLOGY

Measuring KRAS Mutations in Circulating Tumor DNA by Droplet Digital PCR and Next-Generation Sequencing

(2018) Christina Demuth et al.   Translational Oncology

Droplet-based digital PCR and next generation sequencing for monitoring circulating tumor DNA: a cancer diagnostic perspective

(2017) Mathilde Postel et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Crystal digital droplet PCR for detection and quantification of circulating EGFR sensitizing and resistance mutations in advanced non-small cell lung cancer

(2017) Cécile Jovelet et al.   PLoS One

Multi-institutional Oncogenic Driver Mutation Analysis in Lung Adenocarcinoma: The Lung Cancer Mutation Consortium Experience

(2015) Lynette M. Sholl et al.   Journal of Thoracic Oncology

Association ofEGFRL858R Mutation in Circulating Free DNA With Survival in the EURTAC Trial

(2015) Niki Karachaliou et al.   JAMA Oncology

Detection of EGFR mutations in plasma and biopsies from non-small cell lung cancer patients by allele-specific PCR assays

(2014) Britta Weber et al.   BMC CANCER

EGFR delE709_T710insD: A Rare but Potentially EGFR Inhibitor Responsive Mutation in Non–Small-Cell Lung Cancer

(2012) Allison Ackerman et al.   Journal of Thoracic Oncology

Comparison of Epidermal Growth Factor Receptor Mutation Statuses in Tissue and Plasma in Stage I–IV Non-Small Cell Lung Cancer Patients

(2012) Xiao Zhao et al.   RESPIRATION